Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
New IgGNITE study results show 50% lower infusion volume and comparable pharmacokinetic outcomes ver...
Read story
The global study enrolled 161 patients, with topline results expected in Q1 2027 following completio...
Read story
The biotechnology company strengthens its leadership with an experienced biopharma executive as it p...
Read story
Bristol Myers Squibb (BMS) announced positive topline results from the Phase 3 ALOFT-IPF trial evalu...
Read story
Nuravax, Inc. and the Institute for Molecular Medicine (IMM) have announced the publication of Phase...
Read storyPage 1 of 2